rethinkTHC Search
Menu
Study breakdown

German Cannabis Patients Use Much Higher THC Doses Than Expected

Cross Sectional SurveyModerate evidence
The takeaway

German medical cannabis patients using flowers consumed an average daily THC dose of 336 mg, nearly 20 times higher than patients using other cannabis-based medicines.

Forensic toxicologists, traffic safety regulators, and medical cannabis prescribers.

Cannabis flower patients consumed an average 336 mg THC daily vs 17 mg or less for other preparations

What the researchers found

Among 1,030 German medical cannabis patients, 89.9% used cannabis flowers. Average daily THC dose for flower patients was 336 mg compared to 17 mg or less for other cannabis-based medicines. 16.2% used combinations of different cannabis products. 28.4% smoked cannabis flowers despite medical guidance against smoking.

Why it matters

The large gap between THC doses from flowers versus other preparations has direct implications for driving safety assessments and medico-legal evaluations of cannabis patients in traffic incidents.

The numbers in context

1,030 respondents. 89.9% used cannabis flowers. Average daily THC dose: 336 mg (flowers) vs 17 mg or less (other preparations). 16.2% used complex combinations. 28.4% smoked flowers (not recommended medically).

How the study worked

Anonymous nationwide online survey of German medical cannabis patients in Q1 2022. Included both patients with health insurance prescriptions and self-payers for the first time. Analyzed application patterns with focus on the cannabis flower sub-collective.

What this study cannot tell us

Self-reported data from an online survey. Self-selected participants may not represent all medical cannabis patients. No verification of actual THC intake. Q1 2022 data predates Germany recreational legalization.

How to read the evidence

Large survey including self-payers for the first time, but self-report design and online recruitment limit reliability of dose estimates.

When this study was published

2025 publication with Q1 2022 survey data.

The bigger picture

As more countries legalize medical cannabis, understanding actual patient consumption patterns is critical for setting driving thresholds, assessing workplace impairment, and providing accurate forensic assessments.

Questions still open

  • How do these THC doses compare to what is typically prescribed versus what patients actually consume?
  • Should driving regulations differentiate between flower and non-flower cannabis patients?

Read the original research

Individual application patterns of Cannabis-based Medicines in Germany - Descriptive evaluation of a patient survey and discussion from a forensic perspective.

Forensic science international, 367, 112352

Citation

Hundertmark, Marica; Ihlenfeld, André; Landschaft, Assaf; Röhrich, Jörg; Germerott, Tanja; Wunder, Cora. (2025). Individual application patterns of Cannabis-based Medicines in Germany - Descriptive evaluation of a patient survey and discussion from a forensic perspective.. Forensic science international, 367, 112352. https://doi.org/10.1016/j.forsciint.2024.112352

Explore the wider topic